I predicted this a week ago: I anticipate that th
Post# of 145437
Quote:
I anticipate that the FDA will next grant Gilead a 2-week combo trial with remdesivir and an anti-inflamatory, since CytoDyn has apparently rejected being involved.
And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.
Read More: https://investorshangout.com/post/view?id=575...z6LsUJO3lK
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)